万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://www.jcvaonline.com/
https://www.journals.elsevier.com/journal-of-cardiothoracic-and-vascular-anesthesia
3、投稿网址：
https://www.editorialmanager.com/jcva/default.aspx
4、官网邮箱：joel.kaplan@louisville.edu（主编）
5、期刊刊期：月刊，一年出版12期。
2021年7月27日星期二
投稿须知【官网信息】
Guide for Authors
Publication
The Journal of Cardiothoracic and Vascular Anesthesia will consider for publication suitable articles on all topics related to anesthesia for cardiac, vascular, and thoracic surgery. The scope of this Journal is broad and seeks to consolidate all material pertinent to cardiothoracic anesthesiology, including topics from critical care medicine, history, internal medicine, medical education, monitoring, perfusion technology, pharmacology, surgery, and transplantation.
Articles, editorials, letters to the Editor, and other text material in the Journal of Cardiothoracic and Vascular Anesthesia represent the opinion of the authors and do not necessarily reflect the opinion of the Editor, Editorial Board, or Publisher. The Editors and Publisher deny any responsibility or liability for statements and opinions expressed by the authors. Neither the Editor nor the Publisher guarantees, warrants, or endorses any product or service advertised in this publication, nor do they guarantee any claim made by the manufacturer of such product or service.
Authors must send their submissions here.
Authors submitting a manuscript do so with the understanding that if it is accepted for publication, copyright of the article, including the right to reproduce the article in all forms and media, shall be assigned exclusively to the Publisher. Following acceptance for publication, in order to comply with United States copyright law and the requirements of the insurance carrier, the Publisher will require authors of accepted manuscripts and letters to sign a copyright release form.
Article Types
For examples of all article types, see any recent issue of the Journal.
The following article types may be submitted: Research Papers, Case Reports, Review Articles (Regular Review Articles, Emerging Technology Reviews, and Expert Reviews), Feature Articles (E-Challenges & Clinical Decisions, Case Conferences, Pro and Con Articles, Diagnostic Dilemmas, Special Articles [those not easily suited to another type], Editorials, and Letters to the Editor). Potential authors are invited to e-mail the Editorial Office to establish a consultation with an Editor in regard to interest in a proposed submission.
Letters to the Editor may be either published in print or online only.
Research Papers
This article type requires 4 documents: Cover Letter, Title Page, Structured Abstract, and Manuscript. The Manuscript document must have 5 identified sections: Introduction, Methods, Results, Discussion, and References. A detailed description of the statistical approach must be included in the methods section. For meta-analyses and related advanced statistical analyses, a statement from a statistician must be included as part of the cover letter. This signed statement must attest to the validity of the statistical methods and presented results. A list of no more than 8 keywords should be submitted with the manuscript. The manuscript should be double-spaced throughout (A New York Times font with a font size of 12 is preferred. Optional items are Tables, Figures, Video/Sound Clips, and Supplementary Materials. Supplementary materials will only be published electronically. The references must be correctly formatted as per the journal style, as outlined later in this guide for authors.
Review Articles
All Review Articles require the same 4 documents as Research Papers. The Cover Letter should clearly indicate if the submission has been invited. The first paragraph of the Manuscript document should introduce the essential points to be discussed, and the concluding paragraph should express future objectives. A list of no more than 8 keywords should be submitted with the manuscript. The articles should include headings for major segments of the text. The Manuscript document is to be double-spaced throughout (a New York Times Font with a font size of 12 is preferred). The Abstract for a Review Article will be published in paper and online; it should summarize the main text in no more than 250 words, with no headings or references. The references must be correctly formatted as per the journal style, as outlined later in this guide for authors.
Case Reports
This article type requires 3 items: Cover Letter, Title Page, and Manuscript. The Manuscript document should begin with a short introduction to the clinical context of the case and its significance and follow with 3 identified sections: Case Report, Discussion, and References. The references must be correctly formatted as per the journal style, as outlined later in this guide for authors. A brief summary should complete the Discussion. A list of no more that 8 keywords should be submitted with the manuscript. There should be no reference to case report in the title i.e. "A Case Report - ".
Please note that case reports will be considered for peer review and publication if they present new or unique information which has not yet been reported. In general, a minority of case reports will meet the criteria for publication. The journal retains the right to publish case reports only in an electronic format.
Case Conferences
These articles are handled by a Section Editor for Case Conferences. Some offline communication between authors and editors may be required. There are 3 parts to each Case Conference: (1) case presentation, (2) case discussion, and (3) commentary(ies). The case presentation and discussion will originate from 1 institution. Their authors are invited to solicit expert commentators not involved in the case. The case presentation and case discussion should be set up as a case report. The discussion should focus on the perioperative management of the patient. The commentaries provide input from related specialties and/or other viewpoint(s) on anesthetic, surgical, or intensive care management of the case. A commentary should be submitted with its author’s full name, degrees, affiliation, and e-mail address on its first page. The commentators may be from any appropriate medical or medically-related discipline within the same or another institution. The Journal reserves the right to solicit commentaries appropriate to a submitted Case Conference and to make final determination of commentators. Figures, tables, and references from all contributors are desirable to expand the teaching value of the case. Follow the guidelines for preparing figures, video clips, tables, and references. A maximum of 8 keywords should be submitted with the manuscript.
Diagnostic Dilemmas
This cogent article type is in two parts. First, it presents a case with difficult diagnosis, usually resulting from preliminary graphic evidence. The reader is then invited to project a tentative diagnosis. In the second part, the results of further investigation are provided to resolve the dilemma. High quality figures and/or video clips are vital for these submissions. A maximum of 8 keywords should be submitted with the manuscript.
Letters to the Editor
These should be double-spaced, brief, and concisely focused. They should have a title. Cited works must have full, accurate references. A Cover Letter and a Title Page are needed separate from the letter. Figures, video clips, and tables may be included. Letters to the Editor may be either published in print or online only. Keywords are not required for Letters to the Editor.
E-Challenges
These articles are handled by a Section Editor for E-challenges. This article type requires the following elements to be included: 1) Title page 2) Brief non-structured abstract: 200 word max. 3) 4-8 Key Words 4) Background 5) Clinical Case 6) E-Challenge 7) Clinical Course 8) Discussion. The total length should be 1500-2500 words with references.
Submission Checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been identified on the Title Page as the Corresponding Author with contact details:
E-mail address
Full postal address
All authors should be included on the title page in the correct order with their affiliations and degrees
Note that only 1 author can be listed as the Corresponding Author and will be responsible for all communications among the authors and the Journal.
All necessary files have been uploaded:
Cover Letter (all articles):
Addressed to the Editor in Chief
Statement that the authors agree with and take responsibility for the data presented
List of authors as if for signature
Discussion of the article is not expected; save it for the Abstract or Manuscript.
Structured Abstract (Research Papers only):
Seven paragraphed sections, double-line spaced
Key Words
Title Page (all articles):
Title of article; full names of authors in preferred order; separate list of authors by name, title, and institution; notice of Corresponding Author with full contact information including e-mail address;acknowledgements. The authors' names, institutions or geographical locations should not appear in the Manuscript document.
Manuscript (all material except Tables, Figures, Video Clips):
Double-spacing throughout text
Identified major text sections
Proper numbering of pages, text references for tables, figures, video clips, and supplementary materials
Numerical list of References
List of Figure and Video Clip Legends (numbers, titles, necessary notes)
Supplemental Materials
Tables
Figures
Video Clips
Conflict of Interest (see Declaration of Interest section below)
Further considerations
Manuscript and Title Page have been 'spell checked' and 'grammar checked'.
All references mentioned in the References list are cited in the text, and vice versa.
Permission has been obtained for use of copyrighted material (including the Internet), except material owned by the Publisher.
Use generic drug names throughout. Brand names may be inserted following the generic names. The name and city/state/country location of the drug or technology manufacturer must be included after the name of the product.
The author(s) or the name or geographical location of an author's institution should not be identified in the text, header, or footer in the submission except on the Title Page and the Cover Letter.
Journal policies detailed in this guide have been considered.
Ethics in publishing
Please see our information on Ethics in publishing.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Informed consent and patient details
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.
Declaration of competing interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of competing interest statement using this template and upload to the submission system at the Attach/Upload Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required. If there are no interests to declare, please choose the first option in the template. More information.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.
For gold open access articles: Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (more information). Permitted third party reuse of gold open access articles is determined by the author's choice of user license.
Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Open access
Please visit our Open Access page for more information.
Elsevier Researcher Academy
Researcher Academy is a free e-learning platform designed to support early and mid-career researchers throughout their research journey. The "Learn" environment at Researcher Academy offers several interactive modules, webinars, downloadable guides and resources to guide you through the process of writing for research and going through peer review. Feel free to use these free resources to improve your submission and navigate the publication process with ease.
Language (usage and editing services)
Please write your text in good English (American English is strongly preferred). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop (https://webshop.elsevier.com/language-editing-services/language-editing/) or visit our customer support site (https://service.elsevier.com) for more information.
Submission
All text files (Abstract, Manuscript, Tables, Supplementary text) must be presented in Word or a fully-compatible program—NOT .pdf. Most figures can also be submitted in Word.
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process.
Please Submit your article here.
Inquiries and information may be directed to the Editor in Chief at: joel.kaplan@louisville.edu.
Manuscripts will be reviewed by the Editor in Chief, Associate and Section Editors, members of the Editorial Board, and appropriate guest reviewers. Acceptance of a paper for publication is based on the originality and quality of the observation or investigation, and the clarity of the presentation. Clinically relevant material is especially desirable. Good English usage is an essential prerequisite for consideration of the paper.
In all cases the authors must accept the responsibility of conforming to the instructions in this guide. Submissions must conform fully before reviewers will be assigned. Substantial non-conformity may result in outright rejection. If a submitted article is accepted for publication, editorial revisions may be made to aid clarity and understanding without altering the meaning.
……
更多详情：
https://www.elsevier.com/journals/journal-of-cardiothoracic-and-vascular-anesthesia/1053-0770/guide-for-authors
